Swiss National Bank’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.5M	Buy	+319,600	New	+$1.62M	﹤0.01%	1987
2021 Q4	–	Sell	-116,200	Closed	-$591K	–	2729
2021 Q3	$591K	Hold	116,200	–	–	﹤0.01%	2563
2021 Q2	$736K	Hold	116,200	–	–	﹤0.01%	2566
2021 Q1	$898K	Buy	116,200 +22,200	+24%	+$176K	﹤0.01%	2373
2020 Q4	$616K	Buy	94,000 +2,700	+3%	+$19.3K	﹤0.01%	2432
2020 Q3	$607K	Hold	91,300	–	–	﹤0.01%	2317
2020 Q2	$761K	Buy	91,300 +4,400	+5%	+$40.9K	﹤0.01%	2251
2020 Q1	$667K	Hold	86,900	–	–	﹤0.01%	2041
2019 Q4	$722K	Buy	86,900 +3,000	+4%	+$20.2K	﹤0.01%	2292
2019 Q3	$619K	Hold	83,900	–	–	﹤0.01%	2282
2019 Q2	$941K	Buy	83,900 +6,000	+8%	+$62.9K	﹤0.01%	2148
2019 Q1	$837K	Buy	77,900 +2,400	+3%	+$35.5K	﹤0.01%	2166
2018 Q4	$1.14M	Buy	75,500 +2,700	+4%	+$40.1K	﹤0.01%	1926
2018 Q3	$1.35M	Buy	72,800 +12,600	+21%	+$287K	﹤0.01%	1973
2018 Q2	$1.38M	Buy	60,200 +24,600	+69%	+$628K	﹤0.01%	1965
2018 Q1	$1.01M	Buy	35,600 +2,200	+7%	+$62.8K	﹤0.01%	2071
2017 Q4	$705K	Hold	33,400	–	–	﹤0.01%	2287
2017 Q3	$607K	Hold	33,400	–	–	﹤0.01%	2312
2017 Q2	$518K	Buy	33,400 +6,600	+25%	+$99.5K	﹤0.01%	2392
2017 Q1	$463K	Buy	26,800 +4,300	+19%	+$56.6K	﹤0.01%	2402
2016 Q4	$247K	Hold	22,500	–	–	﹤0.01%	2533
2016 Q3	$353K	Hold	22,500	–	–	﹤0.01%	2445
2016 Q2	$230K	Buy	+22,500	New	+$257K	﹤0.01%	2550